System Formulary Update
Loncastuximab Tesirine-lpyl (Zynlonta)
Situation
Loncastuximab tesirine-lpyl 10 mg for injection was approved for addition to the health system formulary at the September 2021 System Pharmacy and Therapeutics Committee meeting.
Background
The following medication was reviewed: Loncastuximab tesirine-lpyl 10 mg for injection
Assessment/Recommendation
Change effective: Tuesday, November 9, 2021
System P&T voted to include the following products on the UNC Health Medication Formulary:
Note: Stock of this formulary product may vary at individual entities